Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Register Now
CE Webinar
Crisis Intervention: Returning to Productivity after a Critical Workplace Incident
On-Demand
This course will educate adjusters and claims professionals on what interventions are available to minimize disruption to the workforce after a cri
Register Now
CE Webinar
Ergonomics
On-Demand
According to the Bureau of Labor and Statistics, two million workers in America suffer from an ergonomic-related or musculoskeletal injury every ye
Workers' Comp
Podcast
Discharge Planning - A Vital Component for RTW
Workers' Comp
Article
A Deeper Look at Utilizing Generic Drugs in Workers’ Comp
According to JAMA, the Journal of the American Medical Asso
Workers' Comp
Article
Ask The Pharmacist: Drug Allergies Versus Side Effects in Workers’ Comp
What's the difference between a drug allergy and a side effect? True medication allergies ar
Workers' Comp
Article
What is the Coventry Outcomes-Based Network Program?
With over 15 years of historical data, the Coventry Outcomes-based Network Program (OBN) is a subset of the Coventry Integrated Network.